Abstract:Background Tumor purity, the proportion of cancerous cells within a tumor mass, is a pivotal factor in oncological research and clinical practice and plays a significant role in the molecular testing workflow, particularly when selecting samples for genomic analysis. Accurate assessment of tumor purity is crucial for understanding tumor behavior, guiding treatment decisions, and predicting patient outcomes. Traditional methods of analyzing hematoxylin and eosin (H&E) stained slides for tumor purity are predominantly pathologist manual readouts. This process is both time-consuming and prone to inter- and intra-observer variability, leading to inconsistencies in diagnosis and treatment planning. Here, we introduce an automated AI-based product designed to streamline tumor purity analysis. The RevealAI-HE digital assay leverages state-of-the-art AI algorithms to automate the segmentation and classification of nuclei in H&E slides, enhancing the accuracy, consistency, and speed of tumor purity assessment. RevealAI-HE aims to assist pathologists in decision-making, support oncology research, streamline molecular testing workflows, and improve personalized care. Methods H&E stained solid tumor slides were imaged using 3D-Histech Pannoramic 1000 and 250 scanners. From this dataset, 104 regions of interest (ROIs) were manually selected to cover a wide range of H&E stain intensities in 14 different indications. A nuclear segmentation model based on StarDist-H&E was deployed on these ROIs, and a pathology expert manually assigned one of three classifications to each nuclei: tumor, immune, and stroma. The resulting ground-truth dataset of over 26,000 classified nuclei was used for training a classifier model based on a ResNet architecture. For model evaluation, the nuclei dataset was randomly split into training (80%) and testing (20%) the model, and the training data was batched and randomized for each training epoch to ensure robustness and generalizability. The nuclear segmentation, nucleus classifier, and tumor purity statistics models were integrated into an end-to-end digital assay (RevealAI-HE) using Reveal Biosciences' proprietary digital assay development pipeline. RevealAI-HE is integrated into Reveal Biosciences' flagship whole slide image management system, ImageDx. Results The RevealAI-HE digital assay's nucleus classification model achieved a high accuracy across all 14 indications. Compared to manual methods, the AI system significantly reduced the time required for tumor purity analysis. Furthermore, the AI model exhibited excellent consistency in its analyses, addressing the issue of variability seen in manual assessments. These results indicate that our AI product, in many aspects, surpasses the current gold standard of tumor purity analysis (pathologist readout), offering a more efficient, accurate, and reproducible approach. Citation Format: Nikolaus R. Wagner, Kaito Kikuchi, Kristen Fukuda, Nikola Spasic, Stacy Littlechild, Sinisa Todorovic, Dragana Stojnev, Masa Jovanovic, Claire Weston. Automating tumor purity assessment: Advanced AI-driven segmentation and classification of nuclei in H&E stained slides [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6178.

Modernizing histopathological analysis: a fully automated workflow for the digital image analysis of the intestinal microcolony survival assay

Image Analysis Algorithms for Immunohistochemical Assessment of Cell Death Events and Fibrosis in Tissue Sections

A machine learning approach toward automating spatial identification of LAG3+/CD3+ cells in ulcerative colitis

Proof of Concept for a Deep Learning Algorithm for Identification and Quantification of Key Microscopic Features in the Murine Model of DSS-Induced Colitis

AI-augmented histopathologic review using image analysis to optimize DNA yield and tumor purity from FFPE slides

Computer analysis of histopathological images for tumor grading

Automated Whole Slide Imaging for Label-Free Histology using Photon Absorption Remote Sensing Microscopy

Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learning

Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development

P777 Deployment of an artificial intelligence tool for precision medicine in ulcerative colitis: Preliminary data from 8 globally distributed clinical sites

Implementation of an automated inclusion system for the histological analysis of murine tissue samples: A feasibility study in DSS-induced chronic colitis

D-CryptO: Deep learning-based analysis of colon organoid morphology from brightfield images

P13.04.B Dissecting high-grade glioma immune infiltration in samples from fluorescence-guided surgery: digital pathology with automated image analysis

Open access to high-content clonogenic analysis

Abstract 6181: Digital pathology workflow: Building a bridge for translational biomarker development in humanized mice

Automated Nuclear Morphometry: A Deep Learning Approach for Prognostication in Canine Pulmonary Carcinoma to Enhance Reproducibility

High-throughput profiling of tissue and tissue model microarrays: Combined transmitted light and 3-color fluorescence digital pathology

Abstract 2336: A prototype for a machine-learning assisted image analysis tool for preclinical in vivo studies

Automated Image Analysis of Hodgkin lymphoma

Label-free tissue scanner for colorectal cancer screening

Abstract 6178: Automating tumor purity assessment: Advanced AI-driven segmentation and classification of nuclei in H&E stained slides